New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 19, 2013
16:22 EDTABC, LMCA, CAH, WAG, CHTR, EA, LULUOn The Fly: Closing Wrap
Stocks on Wall Street were mixed as the ongoing fears over the situation in Cyprus weighed on the S&P, though the Dow was able to eke out a modest gain. Data released before the open showed housing permits rose to multi-year highs, but headlines out of Europe kept the averages under pressure for much of the afternoon... ECONOMIC EVENTS: In the U.S., housing starts climbed 0.8% from the prior month to a 917K rate in February. Building permits rose by 4.6% to a 946K rate, which was significantly ahead of the consensus forecast. In Europe, ongoing fears about how the situation in Cyprus will play out, including renewed worries that the nation will default or be forced to leave the euro zone, sent the euro currency lower against the U.S. dollar. Cyprus' parliament defeated the bank levy bill and afternoon headlines from Bloomberg said the ECB will provide liquidity to that nation, though only within its existing rules... COMPANY NEWS: Liberty Media (LMCA) announced an agreement to pay $2.617B for a 27.3% stake in Charter Communications (CHTR). Charter shares, which gained nearly 10% yesterday as media reports of the Liberty investment circulated, advanced another $2.34, or 2.39%, to $100.38, while Liberty shares closed down 32c, or 0.29%, to $110.34... lululemon (LULU) lost $1.82, or 2.76%, to $64.08 after issuing a recall of its Black Luon pants, citing a sheerness problem. lululemon cut its Q1 revenue and same-store-sales guidance as a result of the recall, and shares were downgraded at Sterne Agee... MAJOR MOVERS: Among the notable gainers was Walgreen (WAG), up $2.31, or 5.44%, to $44.74 after reporting earnings and announcing it agreed to a long-term pharmaceutical distribution agreement with AmerisourceBergen (ABC). AmerisourceBergen shares rose $1.76, or 3.64%, to $50.06 after the agreement, which grants Walgreen the right to buy a stake in AmerisourceBergen. Among the noteworthy losers was Electronic Arts (EA), down $1.56, or 8.34%, to $17.15 after its CEO resigned and the company warned it will likely come in below or near the bottom of its prior guidance. Also lower was Cardinal Health (CAH), down $3.78, or 8.19%, to $42.35 after the company announced its agreement with Walgreen will end in August and the company provided a FY14 EPS view below consensus... INDICES: The Dow was up 3.76, or 0.03%, to 14,455.82; the Nasdaq was down 8.49, or 0.26%, to 3,229.10; and the S&P 500 was down 3.76, or 0.24%, to 1,548.34.
News For CHTR;LMCA;LULU;WAG;ABC;EA;CAH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
October 6, 2015
07:03 EDTABCAmerisourceBergen to acquire PharMEDium Healthcare for $2.575B in cash
Subscribe for More Information
07:02 EDTABCAmerisourceBergen to acquire PharMEDium Healthcare for $2.575B in cash
Subscribe for More Information
October 5, 2015
09:39 EDTEAeSports seen as next big growth opportunity in media
Competitive video game playing in organized leagues, or eSports, is on the verge of reaching mainstream adoption and moving from an engagement tool to a monetization opportunity for video game makers, according to Baird analyst Colin Sebastian, who calls the trend the "biggest media and sports growth opportunity you've never heard of." NEXT BIG THING: eSports could have 200M active and engaged participants as early as next year and can grow from about $200M this year to $1B in revenues by 2018, Sebastian tells investors this morning in a research note. Game publishers such as Activision Blizzard (ATVI), Electronic Arts (EA) and Take-Two Interactive (TTWO) are "natural beneficiaries," according to Sebastian, who believes that eSports has the potential to drive earnings growth and multiple expansion for the sector. eSports is still mainly a tool to help engage and keep core gamers, but Sebastian expects this to change quickly as game makers focus on incremental revenue opportunities and increasing average revenue per user. The analyst also sees "significant opportunities" from eSports for online streaming platforms, like Amazon's (AMZN) Twitch and Google's (GOOG) newer platform, as well as for Microsoft (MSFT), Sony (SNE) and PC and component makers. ANOTHER eSPORTS BULL: Jefferies analyst Mark Lipacis previously told investors that he believes the surging popularity of competitive video gaming on a global basis will benefit game publishers as well as hardware companies like NVIDIA (NVDA). In a note to investors last month, the analyst said that Activision Blizzard had five of the top fifteen most popular games on Twitch in July, and contended that the company looks best positioned among game makers to benefit from the eSports opportunity. On the date of his eSports note, Lipacis upgraded NVIDIA to Buy from Hold, saying secular growth in gaming will trump PC weakness. The company's Gaming Graphics Processing Unit is "under the radar" and has grown 23% annually over the past three years, noted Lipacis, who raised his price target for shares to $30 from $23. PRICE ACTION: In early trading, Activision Blizzard rose 1.4% to $31.90, Electronic Arts gained 1.04% to $67.18 and Take-Two Interactive advanced 0.85% to $29.64.
08:00 EDTEAeSports should drive higher valuations for game makers, says Baird
Subscribe for More Information
06:01 EDTEAElectronic Arts should be bought on any game launch selloff, says Piper Jaffray
Piper Jaffray analyst Michael Olson recommends buying shares of Electronic Arts on any "sell the news" around the November 17 Star Wars Battlefront launch. His analysis shows a "brief, and minor," pullback in shares of major game publishers following the launch of big titles. This selloff historically creates a buying opportunity, however, with publisher shares up an average of 40% in the 12 months following launch, Olson tells investors in a research note. He reiterates an Overweight rating on Electronic Arts with an $86 price target.
October 4, 2015
19:07 EDTCAHCardinal Health sees Cordis acquisition adding more than 20c to FY17 EPS
Subscribe for More Information
October 2, 2015
11:18 EDTABCMorgan Stanley downgrades select pharma stocks amid drug price scrutiny
Morgan Stanley downgraded several stocks in the pharmaceutical sector, dropping drugmakers Valeant (VRX), Gilead (GILD) and Regeneron (REGN) to Equal Weight from Overweight. The firm also downgraded specialty pharmacy Diplomat Pharmacy (DPLO) to Equal Weight and cut its rating on drug distributor AmerisourceBergen (ABC) to Underweight, the firm's equivalent of a sell rating. WHAT'S NEW: Democrats' scrutiny of high drug prices may continue, warned Morgan Stanley analyst David Risinger. As a result, it is hard to predict when Valeant, which generated 14% of its Q2 sales rise from price increases, will see its P/E multiple rise, Risinger believes. The company's lower multiple will hinder its ability to conduct M&A and swap or issue equity, according to Risinger, who set a $200 price target on the stock. Morgan Stanley analyst Matthew Harrison downgraded Gilead, noting that U.S. hepatitis C volume growth has dropped in the last few months. Although Harrison thinks that the U.S. hepatitis C market is still strong, he believes that the data could cause the Street to become concerned about Gilead's fourth quarter and 2016 outlook. He set a $127 price target on the shares. Harrison also downgraded Regeneron, stating his belief that two other drug makers, Alexion (ALXN) and Vertex (VRTX), have stronger near-term appreciation potential. He added that Regeneron has a number of potential negative catalysts, including drug pricing concerns and his belief, based on physician feedback, that the launch of the company's cholesterol drug, Praluent, could miss expectations. He set a $593 price target on the shares. AmerisourceBergen, which provides pharmaceutical sourcing and distribution service to healthcare providers, is the most levered to branded price inflation and that attribute could weigh on the shares, said Risinger, who cut his price target to $93 from $120 on the stock. The uncertain outlook for drug prices could keep the stock range-bound, added the analyst. PRICE ACTION: In morning trading, Valeant dropped 2.3% to $175.50, Gilead declined 1% to $97.26, Regeneron was flat near to $472 per share and AmerisourceBergen slid 1.3% to $93.25.
10:00 EDTABCOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: AGCO (AGCO) downgraded to Underperform from Neutral at BofA/Merrill... AIG (AIG) downgraded to Market Perform with $63 target at FBR Capital... AmerisourceBergen (ABC) downgraded to Underweight from Equal Weight at Morgan Stanley... Astoria Financial (AF) downgraded to Hold from Buy at Sandler O'Neill... Capstone Turbine (CPST) downgraded to Hold from Buy at Craig-Hallum... Diplomat Pharmacy (DPLO) downgraded to Equal Weight from Overweight at Morgan Stanley... Fifth Third (FITB) downgraded to Neutral from Buy at Goldman... Gilead (GILD) downgraded to Equal Weight from Overweight at Morgan Stanley... Henkel (HENKY) downgraded to Neutral from Outperform at Exane BNP Paribas... Horsehead Holding (ZINC) downgraded to Perform from Outperform at Oppenheimer... LPL Financial (LPLA) downgraded to Sell from Neutral at UBS... MYR Group (MYRG) downgraded on electricity outlook at BB&T... Orion Marine (ORN) downgraded on reduced dredging awards at BB&T... QTS Realty Trust (QTS) downgraded to Hold from Buy at Stifel... Quanta Services (PWR) downgraded to Hold from Buy at BB&T... Regeneron (REGN) downgraded to Equal Weight from Overweight at Morgan Stanley... Ryanair (RYAAY) downgraded to Hold from Buy at HSBC... T. Rowe Price (TROW) downgraded to Neutral from Buy at UBS... Telekom Austria (TKAGY) downgraded to Hold from Buy at HSBC... Valeant (VRX) downgraded to Equal Weight from Overweight at Morgan Stanley.
08:37 EDTABCAmerisourceBergen downgraded to Underweight from Equal Weight at Morgan Stanley
Subscribe for More Information
October 1, 2015
10:50 EDTCAHLeerink healthcare services analyst holds analyst/industry conference call
Analyst Larsen, along with Dan Steiber of D2 Pharma Consulting and James Kenney, Jr., of Harvard Pilgrim Health Care, discuss Hillary Care's potential impact to the Prescription Drug Supply Chain, the impact of the Medicaid rebate program and the uptake of bio-similars and generic launches in 2015 on an Analyst/Industry conference call to be held on October 2 at 12 pm.
September 30, 2015
13:33 EDTCHTRFCC review of Charter-TWC deal likely to extend into 1Q16, CTFN says
The FCC's review of Charter Communications' (CHTR) proposed merger with Time Warner Cable (TWC) and Bright House Networks will likely extend into the first quarter of 2016 and could take even longer, CTFN reports, citing an attorney who often deals with telecom issues before the FCC. "...It is virtually impossible for the FCC to complete its review and adopt an order approving the license transfer before 1Q16 and, in my opinion, even getting it done before April 1 is a stretch," Barbara Esbin, a partner at law firm Cinnamon Mueller, told CTFN in an email. Esbin also said that the merger "appears to have drawn none of the heavy flack that felled Comcast (CMCSA)-TWC," a proposal that was nixed by the FCC and DOJ earlier this year, the report says. California utility regulators are also preparing for their own review of the deal since it will particularly effect the southern half of the state, the report says. Reference Link
10:47 EDTCAH, ABCLeerink analyst/industry conference call date/time changed from October 8 10 am
Healthcare Distribution & Technology Larsen, along with Diplomat Pharmacy Chairman & CEO Hagerman and CFO & Secretary/Treasurer Whelan, provide industry insights including the potential impact of Hillary Care, the influence CMS may have on overall drug pricing and recent stock volatility on an Analyst/Industry conference call now being held at a new date and time of September 30 at 5 pm.
September 29, 2015
12:57 EDTCHTRFCC nod for TWC, Charter deal may not be as easy as expected, dealReporter says
Subscribe for More Information
12:40 EDTLULUlululemon October weekly calls active
Subscribe for More Information
11:02 EDTLULURumor: lululemon strength attributed to takeover speculation
Subscribe for More Information
September 28, 2015
09:12 EDTCHTRRovi news a 'small positive first step,' says JPMorgan
Subscribe for More Information
05:32 EDTLULUStocks with implied volatility below IV index mean; LULU ASHR
Subscribe for More Information
September 25, 2015
10:48 EDTCHTRMorgan Stanley cautious on media, but sees several stocks punished too hard
Morgan Stanley cut its price targets on a number of media companies, citing the impact of cord cutting and skinny bundles. The firm also reduced its outlook for the pay-TV sector due to its belief that the adoption of skinny bundles will accelerate, while the outlook for cable TV ads has deteriorated slightly, given macro pressures. The firm kept a Cautious view on the media sector, but also identified several stocks in the space that it thinks have been punished too harshly by investors recently. WHAT'S NEW: TV networks in general, and cable networks in particular, have the highest margins in media and are encountering increased top and bottom line competitive pressures, Morgan Stanley analyst Benjamin Swinburne believes. On the top line, they are being hit by ratings and ad pressures as well as cord cutting and distribution consolidation, the analyst stated. Meanwhile, their profit is being hurt by the increased need to obtain new content and intensified competition for content from new sources like Netflix (NFLX) and Google's (GOOG) YouTube, Swinburne said. However, the analyst thinks that media stocks are "starting to get" cheap, given the leverage that many of the companies carry. Swinburne cuts his price target on 21st Century Fox (FOXA) to $31 from $37, on AMC Networks (AMCX) to $86 from $88, on CBS (CBS) to $46 from $56, on Time Warner (TWX) to $72 from $87 and on Viacom (VIAB) to $48 from $60. He kept Overweight ratings on Fox, AMC and CBS, an Equal Weight rating on Time Warner and an Underweight rating on Viacom. OVERDONE DECLINES: Swinburne believes that the declines in three media stocks - CBS, 21st Century Fox, and AMC Networks - have been overdone, while the decline in Comcast's (CMCSA) stock has also been excessive. CBS and 21st Century Fox are "best positioned for the skinny bundle" and have the cheapest valuations relative to their growth rates, Swinburne believes. Meanwhile, AMC Networks has "content momentum" and its EPS can exceed expectations, the analyst believes. Comcast is gaining share in the broadband Internet market, could take share in video soon, and has sufficient scale and offerings to benefit from the increased popularity of skinny bundles, according to the analyst, who kept an Overweight rating on the stock. The media sector could benefit from consolidation going forward, added Swinburne, who recommended that investors interested in buying potential takeover targets in the space focus on AMC Networks, MSG Networks (MSG) and Dreamworks Animation (DWA). He kept Overweight ratings on all three of those stocks. OTHERS TO WATCH: Besides Comcast, other pay TV companies include DISH Network (DISH) and Charter Communications (CHTR). PRICE ACTION: In early trading, Fox A shares lost 0.5% to $25.83, AMC fell 0.3% to $73.29, CBS added 0.2% to $41, Time Warner was little changed at $67.66 and Comcast A shares added 0.6% to $57.17.
09:09 EDTLULUlululemon recent weakness a buying opportunity, says Baird
Subscribe for More Information
05:34 EDTLULUStocks with implied volatility below IV index mean; LULU ASHR
Subscribe for More Information
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use